|
End-of-day quote
New Zealand S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 4.370 NZD | -0.23% |
|
-2.89% | +29.29% |
| 31/07 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 31/07 | New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire | MT |
| Market Cap | 46Cr 27Cr 23Cr 22Cr 20Cr 37Cr 2.55TCr 37Cr 258.28Cr 100.22Cr 1.31TCr 101.38Cr 99Cr 4.21TCr | P/E 2027 * |
23.3x | P/E 2028 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 49Cr 29Cr 25Cr 23Cr 21Cr 40Cr 2.71TCr 40Cr 275.09Cr 106.75Cr 1.39TCr 107.98Cr 105.62Cr 4.49TCr | EV / Sales 2027 * |
1.61x | EV / Sales 2028 * | 1.4x |
| Free-Float |
22.37% | Yield 2027 * |
0.75% | Yield 2028 * | 0.95% |
| Markets | Quality | ||
|---|---|---|---|
New Zealand S.E.
| AFT | End-of-day quote | |
Australian S.E.
| AFP | Delayed |
Last Transcript : AFT Pharmaceuticals Limited
| 20/24/20 | Rentevrees zet Bel20 onder druk | |
| 19/24/19 | KBC uitblinker op groene beurs | |
| 19/24/19 | Brusselse beurs opent flink hoger | |
| 19/24/19 | Brussel start handelsdag vermoedelijk in het groen | |
| 19/24/19 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | -0.23% | ||
| 1 week | -2.89% | ||
| Current month | -1.58% | ||
| 1 month | -8.58% | ||
| 3 months | +10.08% | ||
| 6 months | +25.21% | ||
| Current year | +29.29% |
| 1 week | 4.32 |  | 4.49 |
| 1 month | 4.23 | | 4.78 |
| Current year | 3.35 | | 4.85 |
| 1 year | 2.56 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 04/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 04/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 22/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 04/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 04/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/07/25 | Buy | Founder | 2,00,000 | 0.1907% | ||
| 26/06/25 | Free | Founder | 17,755 | 0.0169% | ||
| 02/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -2.89% | +68.08% | +23.80% | 27Cr | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,02400Cr | |
| -1.15% | +2.68% | +53.97% | +71.50% | 66TCr | |
| -1.44% | +0.38% | +20.40% | +73.05% | 45TCr | |
| +0.14% | -0.47% | +29.49% | +38.56% | 35TCr | |
| -1.33% | +4.72% | +24.69% | +45.55% | 30TCr | |
| -1.15% | +0.30% | -1.49% | +12.31% | 25TCr | |
| -1.55% | +1.11% | +56.10% | +70.32% | 24TCr | |
| -0.88% | +1.15% | -17.09% | -54.39% | 21TCr | |
| -0.15% | +3.65% | +33.90% | +96.99% | 19TCr | |
| Average | -0.91% | +0.82% | +32.28% | +48.40% | 36.79TCr | |
| Weighted average by Cap. | -1.10% | +0.55% | +36.62% | +66.22% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 30Cr 18Cr 15Cr 14Cr 13Cr 25Cr 1.69TCr 25Cr 171.22Cr 66Cr 866.96Cr 67Cr 66Cr 2.79TCr | 35Cr 20Cr 18Cr 16Cr 15Cr 28Cr 1.92TCr 28Cr 194.57Cr 76Cr 985.18Cr 76Cr 75Cr 3.17TCr |
| Net income | 1.97Cr 1.16Cr 99.83L 93.93L 85.81L 1.61Cr 109.54Cr 1.61Cr 11Cr 4.31Cr 56Cr 4.36Cr 4.26Cr 181.06Cr | 2.48Cr 1.46Cr 1.26Cr 1.18Cr 1.08Cr 2.02Cr 138Cr 2.03Cr 14Cr 5.43Cr 71Cr 5.49Cr 5.37Cr 228.1Cr |
| Net Debt | 2.98Cr 1.76Cr 1.51Cr 1.42Cr 1.3Cr 2.43Cr 165.94Cr 2.44Cr 17Cr 6.52Cr 85Cr 6.6Cr 6.46Cr 274.27Cr | 2.46Cr 1.45Cr 1.25Cr 1.17Cr 1.07Cr 2Cr 136.8Cr 2.01Cr 14Cr 5.38Cr 70Cr 5.44Cr 5.32Cr 226.11Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | NZ$4.370 | -0.23% | 2,192 |
| 03/26/03 | NZ$4.380 | +0.69% | 36,563 |
| 02/26/02 | NZ$4.350 | -1.36% | 12,353 |
| 01/26/01 | NZ$4.410 | -0.68% | 27,717 |
| 31/26/31 | NZ$4.440 | -1.33% | 26,596 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
